Toyota Releases Sales, Production, and Export Results for July 2021

Toyota City, Japan, Aug 30, 2021 – (JCN Newswire via SEAPRWire.com) – Toyota Motor Corporation (TMC) announces its sales, production, and export results for July 2021 as well as the cumulative total from January to July, including those for subsidiaries Daihatsu Motor Co., Ltd. and Hino Motors, Ltd. Global Sales – North America (260,000 units, […]

Volcano IPO Shares Oversubscribed by 176.6 Times

– Leading manufacturer of nameplates and plastic injection moulded parts to MNC customers– Proceeds for purchase of machinery and equipment to expand capacity, grow market share in E&E and automotive industries   KUALA LUMPUR, Mar 26, 2021 – (ACN Newswire) – The shares of Volcano Berhad (VOLCANO) have been oversubscribed by 176.6 times ahead of the Group’s listing on […]

Toyota’s Global Sales and Production Up Year-on-Year in November for Third Consecutive Month

TOKYO, Dec 25, 2020 – (JCN Newswire) – Toyota Motor Corporation (TMC) announces its sales, production, and export results for November 2020 as well as the cumulative total from January to November 2020, including those for subsidiaries Daihatsu Motor Co., Ltd. and Hino Motors, Ltd. Global Sales Results in November were driven primarily by sales […]

Toyota’s Global Sales and Production Up Year-on-Year in October for Second Consecutive Month

Toyota City, Japan, Nov 27, 2020 – (JCN Newswire) – Toyota Motor Corporation (TMC) announces its sales, production, and export results for October 2020 as well as the cumulative total from January to October 2020, including those for subsidiaries Daihatsu Motor Co., Ltd. and Hino Motors, Ltd. Global Sales Results in October were driven primarily […]

AbbVie and Eisai Announce an approval for additional indication of HUMIRA

TOKYO, Nov 27, 2020 – (JCN Newswire) – AbbVie GK and Eisai Co., Ltd. today announced an approval of additional indication of HUMIRA (generic name: adalimumab [recombinant], hereafter “HUMIRA”), a fully human anti-TNFalpha monoclonal antibody, for the treatment of pyoderma gangrenosum (hereafter “PG”). HUMIRA was granted orphan drug designation for the treatment of PG in […]